BLOG

Sunday, June 7, 2020

Sebi censures Astrazeneca promoter, Elliot Group for unfair trade practices

Sebi said that the entire procedure was intended to dilute the reverse book building mechanism for discovery of delisting price of the scrip as per stipulations

from Home Page https://ift.tt/3dBeHnP
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...